Flu Season Linked to Increased Heart Damage: New Research Reveals Unexpected Pathway
Influenza vaccination offers a degree of protection, but a newly discovered mechanism explains how the virus can directly contribute to heart muscle damage, potentially increasing the risk of cardiac events during flu season. Years of observation have indicated a correlation between rising heart attack rates and the annual influenza outbreak, but the underlying cause remained elusive – until now.
The Immune System’s Unexpected Role
Researchers studying tissue samples from patients who succumbed to influenza uncovered a surprising pathway of infection. A specific type of immune cell, normally tasked with fighting off viruses, becomes infected within the lungs. Instead of neutralizing the threat, these compromised cells then migrate to the heart, acting as carriers for the virus.
“These cells act as a Trojan horse for the immune system during infection,” explained a co-author of the study from Icahn School of Medicine at Mount Sinai. This process allows the infection to establish itself in the lung and then transmit the virus directly to the heart muscle cells.
Type 1 Interferon: A Double-Edged Sword
Once inside the heart, the infected immune cells don’t simply combat the virus. They begin to produce excessive amounts of a protein called type 1 interferon. While typically a crucial component of the immune response, this overproduction proves detrimental, actively causing damage to the heart muscle and weakening its function. This discovery sheds light on why influenza can lead to serious cardiovascular complications.
mRNA Vaccines Offer Hope
The research, published in the medical journal Immunity, also offers a potential avenue for improved protection. Experiments demonstrated that the mRNA vaccine – the same technology used in many COVID-19 vaccines – can mitigate this heart damage.
In laboratory settings, the mRNA vaccine effectively controlled the activity of type 1 interferon, significantly reducing damage to heart muscle cells both in vitro and in experiments conducted on mice. Furthermore, the vaccine enhanced the muscles’ ability to efficiently pump blood.
Future Treatments on the Horizon
According to researchers, these findings are critical for developing new and targeted treatments. “These new findings enhance the opportunities for developing new treatments, which are urgently needed given the current lack of effective options for preventing heart damage” caused by influenza. The understanding of this specific mechanism opens doors for interventions designed to protect the heart during and after an influenza infection, potentially saving lives and reducing the burden on healthcare systems during peak flu seasons.
